RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 13 - per page Next page
Order by
Two papers on Neo-Penotran® Forte and Neo-Penotran® Forte-L have been accepted for presentation at the 4'th World Conference on Vaginitis, Costa Rica, 10-13 Jan 2004
Two papers on Embil's novel triple-active topical products (Neo-Penotran® Forte and Neo-Penotran® Forte-L) have been accepted for presentation at the 4'th World Conference on Vaginitis, Costa Rica, 10-13 Jan 2004 More
HEALTHPOINT® Launches COOK® Biotech's Oasis® Wound Matrix Disribution in Canada
HEALTHPOINT Canada, a division of HEALTHPOINT Ltd., , began marketing COOK Biotech Incorporated's patented wound matrix product, Oasis, in Canada this month through a distribution partnership with Trudell Medical Marketing Limited. More
Arkansas USA Startup Company, Omnibalm, therapeutic skin creams
UAMS Arkansas BioVentures Startup Inks Deal With New York Drug Store Chain More
Foamix to Present at the Upcoming American Academy of Dermatology Meeting, February 18-22, 2005
Foamix is partnering with leading phamaceutical companies in developing their drugs in foam formulations. The company will present at the upcoming American Academy of Dermatology meeting in New Orleans on February 18-22, 2005 More
Foamix enters new state-of-the-art facility
Ness Ziona ISRAEL, April 7, 2005 - Foamix Ltd., a leader in developing innovative topical delivery systems, enters new state-of-the-art facility. More
US Army Grants License for Skin Protectant Technology to DPT,
Prescription Cream Will Help Guard Soldiers Against Chemical Warfare Agents More
HEALTHPOINT Focused on Supply Availability, Service to Customers as IODOSORB(R) Gel, IODOFLEX(R) Pad Licensing Agreement Expires
HEALTHPOINT will strive for an uninterrupted supply of IODOSORB(R) Gel and IODOFLEX(R) Pad absorbent antimicrobials to their customers as the licensing agreement with Smith & Nephew for these products expires. More
Warner Chilcott and Foamix Collaborate on Foam Product for the Treatment of Acne
Warner Chilcott Company, Inc. and Foamix Ltd. announced today that the two companies have signed an agreement to jointly develop an antibiotic foam for the treatment of acne. More
HEALTHPOINT® Introduces TRISEPTIN® Water-Optional, Breakthrough Healthcare Personnel Handwashing Product
First and Only Water-Optional Handwash Helps Fight Nosocomial Infections in Hospitals; Helps Standardize Hospital Handwashing, Increases Efficacy, Improves Handwashing Compliance More
Tamarkin and IBI enter acne licensing agreement
Tamarkin Pharmaceutical Innovation Ltd. and Istituto Biochimico Italiano Giovanni Lorenzini (IBI) S.p.A., have announced the signing of a licensing agreement for IBI to develop TU-2100 as a topical anti-acne medication More
Displaying 1..10 of 13 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
The World Dermatological Market Outlook 2010-2024
Nov 2009 - 142 pages - $2,350
The Dermatology Market Outlook to 2016
Jul 2011 - 96 pages - $3,835
Bacterial Conjunctivitis - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends
Jul 2011 - 150 pages - $3,995
Bacterial Infections Therapy Area Pipeline Report
Nov 2010 - 4441 pages - $1,495
Diabetic Foot Infection (DFI) - Pipeline Review, Q1 2011
Jan 2011 - 20 pages - $500
Bacterial Conjunctivitis - Pipeline Review, Q2 2011
Jun 2011 - 38 pages - $500
Deals and alliances in dermatological diseases
Jun 2006 - 434 pages - $2,495
Hepatitis A Infection - Pipeline Review, Q1 2011
Mar 2011 - 26 pages - $500
Dermatological Drugs: World Market 2011-2026
Nov 2010 - 189 pages - $2,350
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us